CellPilot™: Tailor Immune Cell Function with Unmatched Flexibility and Scale6 Nov 20256 Nov 2025Flyers
Speed Meets Precision: Tailored Immune Cell Function through Rapid Quantitative Immunology6 Nov 20256 Nov 2025White Papers
Accelerating Cell Therapy: Navigating Immune Mediation with Comprehensive Cell Interaction Screening6 Nov 20256 Nov 2025White Papers
A Configurable, Cross-Modality Extracellular Vesicle Standard (EV-CMS) Enables Quantitative Evaluation Across Nanotechnology Platforms6 Nov 20256 Nov 2025Posters
Selective Programming Drives Faster Expansion of Antigen-Specific T cells to Improve Cell Therapy Manufacturing and Outcomes6 Nov 20256 Nov 2025Posters
High Throughput Screening of a Programmable Cellular Interface (sbPCI) Rapidly Identifies Configurations Capable of Expanding T Cell Subsets Without Isolation6 Nov 20256 Nov 2025Posters
StimulusBio CEO Presents at TLSF 2024: Non-Dilutive Funding for Life Science Companies7 Nov 202415 Sep 2025Events
The Science of Success: Transforming Scientific Concepts into Marketable Products with Stacie Frye, co-founder and CCO of Stimulus Bio30 Oct 202415 Nov 2024Podcasts
Empowering Rapid Product Adaptation through Market Insights and Product Definition28 Jun 20243 Sep 2024Case Studies
Positioning our Affiliate, Van Heron Labs, as a Premier New Player in Cell and Gene Therapy12 Jun 202428 Jun 2024Case Studies
